Methods for treating immune-mediated dengue fever infections and antibodydependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome

Details for Australian Patent Application No. 2009270805 (hide)

Owner TRINITY THERAPEUTICS, INC.

Inventors Bodie, Neil M.

Agent Callinan

Pub. Number AU-A-2009270805

PCT Pub. Number WO2010/009380

Priority 61/081,943 18.07.08 US

Filing date 17 July 2009

Wipo publication date 21 January 2010

International Classifications

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

3 March 2011 PCT application entered the National Phase

  PCT publication WO2010/009380 Priority application(s): WO2010/009380

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009270809-Ambient cure solvent-based coatings for writable-erasable surfaces

2009270801-Continuous process for converting natural gas to liquid hydrocarbons